Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve To consider and approve ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Johnson Pharmacare Ltd has informed BSE that its Board of Directors will meet on Thursday, 12 February 2026 at the registered office in Ahmedabad. The key agenda item is to consider and approve the unaudited financial results for the quarter ended 31 December 2025 (Q3 FY26). The trading window for the stock has been closed from 1 January 2026 and will remain closed until 48 hours after the results are declared. Signed by Rajender Parsad, Additional Director (DIN: 10871533).
This is a routine regulatory intimation ahead of the Q3 FY26 earnings announcement. Investors should watch for the results release on or shortly after 12 February 2026; no material corporate action is indicated in this filing.